Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jin Medical International (ZJYL) Non-Current Assets (2022 - 2025)

Jin Medical International's Non-Current Assets history spans 4 years, with the latest figure at $9.2 million for Q3 2025.

  • For Q3 2025, Non-Current Assets rose 209.1% year-over-year to $9.2 million; the TTM value through Sep 2025 reached $9.2 million, up 209.1%, while the annual FY2025 figure was $9.2 million, 209.1% up from the prior year.
  • Non-Current Assets for Q3 2025 was $9.2 million at Jin Medical International, up from $3.0 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $9.2 million in Q3 2025 and bottomed at $1.8 million in Q3 2023.
  • The 4-year median for Non-Current Assets is $2.5 million (2022), against an average of $4.0 million.
  • The largest annual shift saw Non-Current Assets dropped 12.22% in 2023 before it surged 209.1% in 2025.
  • A 4-year view of Non-Current Assets shows it stood at $2.0 million in 2022, then dropped by 12.22% to $1.8 million in 2023, then soared by 66.96% to $3.0 million in 2024, then soared by 209.1% to $9.2 million in 2025.
  • Per Business Quant, the three most recent readings for ZJYL's Non-Current Assets are $9.2 million (Q3 2025), $3.0 million (Q3 2024), and $1.8 million (Q3 2023).